Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,607 total articles
Lifecore Biomedical has agreed to be acquired by Webster Equity Partners in a transaction valued up to $663.7 million including contingent value rights based on future performance milestones. Common stockholders will receive $6.28 per share in cash at closing, representing a 49.5% premium, plus CVRs up to $160 million contingent on milestones throu…
GRI Bio, Inc., a clinical-stage biotech company developing therapies for fibrotic and autoimmune diseases, announced that its CEO and CSO will present at the upcoming 10th IPF Summit. They will share insights from Phase 2a clinical development of GRI-0621, an oral RAR β/γ-selective agonist targeting idiopathic pulmonary fibrosis (IPF). The presenta…
MBody AI Ltd. announced that CEO John Fowler will present at the Lytham Partners Fall 2026 Investor Conference, showcasing the company's autonomous robot workforce platform and growth progress. The company now operates robot fleets in eleven U.S. states and Canada, servicing approximately 600 million square feet. They plan to use recent capital rai…
Idaho Copper Corporation announced that its CEO and Executive Chairman will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference. The company aims to engage institutional investors and highlight advancements in its flagship CuMo copper-molybdenum-silver project, emphasizing its status as one of the largest undeveloped copp…
Orrstown Bank has launched a newly redesigned website, Orrstown.com, featuring enhanced navigation, improved search, better mobile experience, and expanded financial education resources. The upgrade reflects the bank's commitment to responding to client feedback and improving accessibility while maintaining existing online banking platforms unchang…
Powell Max Limited (PMAX) announced a share exchange agreement to acquire a minority stake in Blackrod Holdings, LLC, the parent company of Remington Firearms, with an exclusive 12-month option to acquire majority ownership. This move aligns with PMAX's strategy to expand into new markets and leverage the iconic Remington brand for growth. Both com…
Carlsmed, Inc. appoints Richard Heppenstall as Chief Financial Officer, replacing Leo Greenstein. The company is entering a pivotal growth phase with new product launches and expanded CMS reimbursement for their AI-driven personalized spine surgery solutions. Carlsmed reaffirms its 2026 revenue guidance, targeting $74 to $78 million, a 50% increase…
DLH Holdings Corp. has been awarded a task order valued at up to $19.1 million by the National Institutes of Health's Center for Information Technology to provide risk management framework and cybersecurity operations support. This contract spans up to three years and includes services such as security assessment, vulnerability management, incident…
Achieve Life Sciences announced that it will present new data from the ORCA-OL trial demonstrating 52 weeks of cytisinicline treatment efficacy for cigarette smoking and e-cigarette cessation. The open-label study involves 475 adults and evaluates sustained abstinence, with cytisinicline showing potential as a treatment for nicotine dependence. The…
Silexion Therapeutics announced promising translational research findings showing that its RNAi therapeutic candidate SIL204 leverages native serum lipids for efficient cellular uptake and potent KRAS oncogene silencing in cancer cells. This mechanism supports systemic subcutaneous administration without requiring artificial carriers, aligning with…
Daré Bioscience announced the issuance of a new US patent strengthening the intellectual property for DARE-HPV, a proprietary fixed-dose formulation of lopinavir and ritonavir designed as a non-surgical, topical treatment for persistent high-risk HPV infection, currently in Phase 2 clinical trials with topline results expected in 2027. The program …
Foresight Autonomous Holdings Ltd. has signed a non-binding term sheet to acquire a 50.01% stake in a company developing two data centers in Warsaw and Wroclaw, Poland, with a combined planned capacity of 270 MW. This move broadens Foresight's technology market reach beyond its 3D perception systems to the data center sector in a growing European m…
Kaltura (Nasdaq: KLTR) has won the Best Interactive Content Platform award at the 2026 Digiday Technology Awards for its Agentic Avatars, a cutting-edge AI-driven platform that creates conversational, personalized digital experiences to boost engagement and sales leads while reducing support costs. This recognition underscores Kaltura's leadership …
Paychex, a leading provider of HR, payroll, and benefits solutions, earned a 5-star rating on Newsweek's America's Greatest Companies 2026 list. The recognition evaluates companies on financial strength, market performance as an employer, innovation, and environmental sustainability. Paychex highlighted its AI-powered WISE engine, helping customers…
Lantheus Holdings has initiated dosing in the SPARROW Phase 2/3 registrational trial for LNTH-2401, a gallium-68-labelled PET imaging agent targeting the GRPR biomarker in prostate cancer. This trial aims to assess the sensitivity and specificity of LNTH-2401 PET/CT imaging compared to histopathology in approximately 400 patients, potentially expan…
Humacyte, Inc., a Nasdaq-listed biotechnology company, has appointed Scott Coward and Paul Kuznik to its Board of Directors. These additions bring significant expertise in commercialization, leadership, and vascular healthcare, supporting Humacyte's ongoing product launches, including their regenerative tissue products for dialysis access and vascu…
Keros Therapeutics, a clinical-stage biopharmaceutical company, announced dosing of the first patient in its Phase 2 trial evaluating rinvatercept in patients with Duchenne muscular dystrophy (DMD). The trial aims to assess safety, tolerability, and functional improvements in late-ambulatory and early non-ambulatory DMD patients, signaling progress…
SHF Holdings, Inc. (Safe Harbor Financial), a fintech platform serving the cannabis and hemp financial services sector, announced its board-approved 1-for-12 reverse stock split effective September 30, 2026. The move, approved by shareholders in November 2025, consolidates every 12 shares into one share to potentially enhance the stock's marketabil…
Core Molding Technologies announced the promotion of Michael J. Gayford to Chief Operating Officer, effective immediately. Gayford will oversee North American operations and lead initiatives for operational excellence, program management, research and development, and strategic growth. With over 25 years of experience and a key role in the company …
DeFi Development Corp. (Nasdaq: DFDV) announced a 10% growth in its Solana (SOL) treasury over six weeks, surpassing 2.5 million SOL holdings valued at $309 million. The company’s shares have outperformed SOL and the Nasdaq-100 significantly this quarter. DFDV attributes growth to increased SOL accumulation, staking operations, and its CHAD preferr…
4D Molecular Therapeutics (Nasdaq: FDMT) announced the initiation of the global Phase 3 4SIGHT clinical trial for its lead product candidate, 4D-150, targeting diabetic macular edema (DME), a large and underserved retinal disease market. This follows encouraging two-year results from the SPECTRA trial demonstrating safety, durable vision improvemen…
Allarity Therapeutics, a clinical-stage pharmaceutical company, has expanded its in-house laboratory capabilities to include proteomics and cell line research. This expansion aims to deepen the understanding of the mechanism of action of its lead cancer drug candidate, stenoparib, and to broaden the range of research services offered to external pa…
Comstock Resources, Inc. announced a $1.65 billion strategic partnership agreement with Azerbaijan's SOCAR to jointly develop the Haynesville Shale natural gas assets. The agreement includes plans for SOCAR to market natural gas as LNG internationally, leveraging the assets' proximity to Gulf export facilities. The definitive purchase agreement is …
ALX Oncology announced the publication in Nature Medicine of positive Phase 2 clinical trial results (ASPEN-06) demonstrating that evorpacept combined with trastuzumab, ramucirumab, and paclitaxel significantly improved response rates in patients with HER2-positive gastric cancer compared to control treatments. The data revealed a 40.3% objective r…
FTI Consulting announced the addition of Jacopo Barontini as Senior Managing Director and Head of Turnaround & Restructuring in Italy, along with Fulvio Taglialatela as a Managing Director in Milan. These appointments bolster the firm's capabilities to assist companies and creditors in navigating complex restructuring and turnaround challenges amid…
